Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Ribi ImmunoChem and Schering-Plough sign distribution agreement for Melacine

March 18, 1998

Techniclone to begin TNT clinical trials using unique delivery system

March 16, 1998

Genentech and DAKO establish development agreement for HER2 detection

March 13, 1998

Patient enrollment completed for phase I/II pancreatic cancer trial

March 13, 1998

Avicidin advances to phase II

March 5, 1998

DiagnoCure signs agreements related to development of targeted nanoerythrosomes

March 4, 1998

Phase I/II trial results reported for OncoVax-P formulated with JenVax-100a

March 3, 1998

IDEC-Y2B8/rituximab combination enters phase III

Feb. 27, 1998

UCSF receives green light to develop new breast cancer therapy

Feb. 24, 1998

Maxamine progresses to phase III in AML

Feb. 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...